148 related articles for article (PubMed ID: 24243882)
1. Evolving gonococcal antimicrobial resistance: research priorities and implications for management.
Hook EW; Van Der Pol B
Sex Transm Infect; 2013 Dec; 89 Suppl 4():iv60-2. PubMed ID: 24243882
[TBL] [Abstract][Full Text] [Related]
2. Gonococcal antimicrobial resistance: challenges for public health control.
Ndowa FJ; Ison CA; Cole MJ; Lusti-Narasimhan M
Sex Transm Infect; 2013 Dec; 89 Suppl 4():iv3-4. PubMed ID: 24243877
[No Abstract] [Full Text] [Related]
3. Gonococcal antimicrobial resistance: the implications for public health control.
Ndowa FJ; Ison CA; Lusti-Narasimhan M
Sex Transm Infect; 2013 Dec; 89 Suppl 4():iv1-2. PubMed ID: 24243872
[No Abstract] [Full Text] [Related]
4. Antimicrobial resistance monitoring in Neisseria gonorrhoeae and strategic use of funds from the Global Fund to set up a systematic Moroccan gonococcal antimicrobial surveillance programme.
Hançali A; Ndowa F; Bellaji B; Bennani A; Kettani A; Charof R; El Aouad R
Sex Transm Infect; 2013 Dec; 89 Suppl 4():iv24-7. PubMed ID: 24037141
[TBL] [Abstract][Full Text] [Related]
5. Moving forward in tackling antimicrobial resistance: WHO actions.
Lusti-Narasimhan M; Pessoa-Silva CL; Temmerman M
Sex Transm Infect; 2013 Dec; 89 Suppl 4():iv57-9. PubMed ID: 24202206
[TBL] [Abstract][Full Text] [Related]
6. Gonorrhoea and gonococcal antimicrobial resistance surveillance networks in the WHO European Region, including the independent countries of the former Soviet Union.
Unemo M; Ison CA; Cole M; Spiteri G; van de Laar M; Khotenashvili L
Sex Transm Infect; 2013 Dec; 89 Suppl 4():iv42-6. PubMed ID: 24243879
[TBL] [Abstract][Full Text] [Related]
7. Trends in antimicrobial resistance in Neisseria gonorrhoeae in the USA: the Gonococcal Isolate Surveillance Project (GISP), January 2006-June 2012.
Kirkcaldy RD; Kidd S; Weinstock HS; Papp JR; Bolan GA
Sex Transm Infect; 2013 Dec; 89 Suppl 4():iv5-10. PubMed ID: 24243881
[TBL] [Abstract][Full Text] [Related]
8. Two decades of the gonococcal antimicrobial surveillance program in South America and the Caribbean: challenges and opportunities.
Dillon JA; Trecker MA; Thakur SD;
Sex Transm Infect; 2013 Dec; 89 Suppl 4():iv36-41. PubMed ID: 24243878
[TBL] [Abstract][Full Text] [Related]
9. Monitoring antimicrobial resistance in Neisseria gonorrhoeae in selected countries of the WHO South-East Asia Region between 2009 and 2012: a retrospective analysis.
Bala M; Kakran M; Singh V; Sood S; Ramesh V;
Sex Transm Infect; 2013 Dec; 89 Suppl 4():iv28-35. PubMed ID: 24243876
[TBL] [Abstract][Full Text] [Related]
10. Gonococcal antimicrobial resistance: perspectives from the African region.
Ndowa FJ; Francis JM; Machiha A; Faye-Kette H; Fonkoua MC
Sex Transm Infect; 2013 Dec; 89 Suppl 4():iv11-5. PubMed ID: 24243873
[TBL] [Abstract][Full Text] [Related]
11. Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the WHO Western Pacific Region, 2004.
WHO Western Pacific Gonococcal Antimicrobial Surveillance Programme
Commun Dis Intell Q Rep; 2006; 30(1):129-32. PubMed ID: 16637241
[TBL] [Abstract][Full Text] [Related]
12. Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the WHO Western Pacific and South East Asian regions, 2007-2008.
; ; Tapsall JW; Limnios EA; Abu Bakar HM; Darussalam B; Ping YY; Buadromo EM; Kumar P; Singh S; Lo J; Bala M; Risbud A; Deguchi T; Tanaka M; Watanabe Y; Lee K; Chong Y; Noikaseumsy S; Phouthavane T; Sam IC; Tundev O; Lwin KM; Eh PH; Goarant C; Goursaud R; Bathgate T; Brokenshire M; Latorre L; Velemu E; Carlos C; Leano S; Telan EO; Goh SS; Koh ST; Ngan C; Tan AL; Mananwatte S; Piyanoot N; Lokpichat S; Sirivongranson P; Fakahau M; Sitanilei H; Hung le V
Commun Dis Intell Q Rep; 2010 Mar; 34(1):1-7. PubMed ID: 20521493
[TBL] [Abstract][Full Text] [Related]
13. Core groups, antimicrobial resistance and rebound in gonorrhoea in North America.
Chan CH; McCabe CJ; Fisman DN
Sex Transm Infect; 2012 Apr; 88(3):200-4. PubMed ID: 22169277
[TBL] [Abstract][Full Text] [Related]
14. Australian Gonococcal Surveillance Programme, 1 April to 30 June 2019.
Lahra MM; Hogan TR;
Commun Dis Intell (2018); 2020 May; 44():. PubMed ID: 32418509
[No Abstract] [Full Text] [Related]
15. Current and future treatment options for gonorrhoea.
Ison CA; Deal C; Unemo M
Sex Transm Infect; 2013 Dec; 89 Suppl 4():iv52-6. PubMed ID: 24106339
[TBL] [Abstract][Full Text] [Related]
16. The prevalence and antibiotics susceptibility pattern of Neisseria gonorrhoeae in patients attending OPD clinics at St. Mary's Hospital Lacor Uganda.
Amito Florence P; Otim F; Okongo F; Ogwang M; Greco D
J Prev Med Hyg; 2012 Dec; 53(4):186-9. PubMed ID: 23469585
[TBL] [Abstract][Full Text] [Related]
17. Gonococcal antimicrobial resistance.
Sood S
Indian J Med Microbiol; 2015; 33(3):341-2. PubMed ID: 26068331
[No Abstract] [Full Text] [Related]
18. Antimicrobial susceptibility of Neisseria gonorrhoeae in Greece: data for the years 1994-2004.
Stathi M; Flemetakis A; Miriagou V; Avgerinou H; Kyriakis KP; Maniatis AN; Tzelepi E
J Antimicrob Chemother; 2006 Apr; 57(4):775-9. PubMed ID: 16492719
[TBL] [Abstract][Full Text] [Related]
19. Gonococcal resistance: evolving from penicillin, tetracycline to the quinolones in South Africa -- implications for treatment guidelines.
De Jongh M; Dangor Y; Adam A; Hoosen AA
Int J STD AIDS; 2007 Oct; 18(10):697-9. PubMed ID: 17945048
[TBL] [Abstract][Full Text] [Related]
20. Retrospective analysis of antimicrobial susceptibility trends (2000-2009) in Neisseria gonorrhoeae isolates from countries in Latin America and the Caribbean shows evolving resistance to ciprofloxacin, azithromycin and decreased susceptibility to ceftriaxone.
Starnino S; ; Galarza P; Carvallo ME; Benzaken AS; Ballesteros AM; Cruz OM; Hernandez AL; Carbajal JL; Borthagaray G; Payares D; Dillon JA
Sex Transm Dis; 2012 Oct; 39(10):813-21. PubMed ID: 23001269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
